Cargando…

Tumor Lysis Syndrome after Combination Therapy of Nivolumab and Sorafenib in a Woman with Advanced Hepatocellular Carcinoma

Tumor lysis syndrome (TLS) is a life-threatening emergency that usually develops in rapidly proliferating hematologic malignancies or advanced solid tumor following cytotoxic chemotherapy or therapeutic interventions. TLS is especially rare in patients with hepatocellular carcinoma (HCC). Therefore,...

Descripción completa

Detalles Bibliográficos
Autores principales: Yen, Tsai-Hung, Chang, Chung-Hsin, Shiu, Sz-Iuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443662/
https://www.ncbi.nlm.nih.gov/pubmed/32884512
http://dx.doi.org/10.1159/000508583